CA Stock MarketDetailed Quotes

GTTX GeneTether Therapeutics Inc

Watchlist
  • 0.050
  • 0.0000.00%
15min DelayMarket Closed Jun 24 15:19 ET
1.94MMarket Cap-3571P/E (TTM)

GeneTether Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-28.07%1.03M
-25.37%1.25M
-24.06%1.36M
-24.06%1.36M
-32.23%1.36M
-39.55%1.43M
-45.93%1.68M
898.49%1.8M
898.49%1.8M
--2.01M
-Cash and cash equivalents
-28.07%1.03M
-25.37%1.25M
-24.06%1.36M
-24.06%1.36M
-32.23%1.36M
-39.55%1.43M
-45.93%1.68M
898.49%1.8M
898.49%1.8M
--2.01M
Total current assets
-29.86%1.1M
-25.77%1.25M
-27.43%1.41M
-27.43%1.41M
-35.34%1.45M
-41.70%1.57M
-48.37%1.69M
424.80%1.94M
424.80%1.94M
--2.25M
Non current assets
Regulatory assets
-48.00%73.27K
-86.41%1.5K
-68.17%47.27K
-68.17%47.27K
--91.82K
--140.9K
--11.01K
--148.49K
--148.49K
----
Liabilities
Current liabilities
-accounts payable
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
--113.72K
-Total tax payable
---1
--0
--0
--0
-200.00%-1
--0
--0
--0
--0
--1
Current liabilities
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
--113.72K
Non current liabilities
Total non current liabilities
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
--113.72K
Shareholders'equity
Share capital
0.12%4.2M
0.28%4.2M
0.51%4.2M
0.51%4.2M
0.81%4.2M
1.14%4.19M
1.27%4.19M
234.56%4.18M
234.56%4.18M
--4.16M
-common stock
0.12%4.2M
0.28%4.2M
0.51%4.2M
0.51%4.2M
0.81%4.2M
1.14%4.19M
1.27%4.19M
234.56%4.18M
234.56%4.18M
--4.16M
Additional paid-in capital
13.10%1.64M
14.90%1.64M
10.60%1.63M
10.60%1.63M
-1.83%1.39M
8.88%1.45M
17.52%1.42M
87.32%1.48M
87.32%1.48M
--1.42M
Gains losses not affecting retained earnings
-32.46%-219.19K
5.63%-206.91K
12.96%-174.87K
12.96%-174.87K
13.66%-195.9K
-86.91%-165.48K
-66,945.12%-219.25K
---200.92K
---200.92K
---226.9K
Total equity
-29.86%1.1M
-25.77%1.25M
-27.43%1.41M
-27.43%1.41M
-35.34%1.45M
-41.70%1.57M
-48.37%1.69M
424.80%1.94M
424.80%1.94M
--2.25M
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -28.07%1.03M-25.37%1.25M-24.06%1.36M-24.06%1.36M-32.23%1.36M-39.55%1.43M-45.93%1.68M898.49%1.8M898.49%1.8M--2.01M
-Cash and cash equivalents -28.07%1.03M-25.37%1.25M-24.06%1.36M-24.06%1.36M-32.23%1.36M-39.55%1.43M-45.93%1.68M898.49%1.8M898.49%1.8M--2.01M
Total current assets -29.86%1.1M-25.77%1.25M-27.43%1.41M-27.43%1.41M-35.34%1.45M-41.70%1.57M-48.37%1.69M424.80%1.94M424.80%1.94M--2.25M
Non current assets
Regulatory assets -48.00%73.27K-86.41%1.5K-68.17%47.27K-68.17%47.27K--91.82K--140.9K--11.01K--148.49K--148.49K----
Liabilities
Current liabilities
-accounts payable -39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K--113.72K
-Total tax payable ---1--0--0--0-200.00%-1--0--0--0--0--1
Current liabilities -39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K--113.72K
Non current liabilities
Total non current liabilities -39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K--113.72K
Shareholders'equity
Share capital 0.12%4.2M0.28%4.2M0.51%4.2M0.51%4.2M0.81%4.2M1.14%4.19M1.27%4.19M234.56%4.18M234.56%4.18M--4.16M
-common stock 0.12%4.2M0.28%4.2M0.51%4.2M0.51%4.2M0.81%4.2M1.14%4.19M1.27%4.19M234.56%4.18M234.56%4.18M--4.16M
Additional paid-in capital 13.10%1.64M14.90%1.64M10.60%1.63M10.60%1.63M-1.83%1.39M8.88%1.45M17.52%1.42M87.32%1.48M87.32%1.48M--1.42M
Gains losses not affecting retained earnings -32.46%-219.19K5.63%-206.91K12.96%-174.87K12.96%-174.87K13.66%-195.9K-86.91%-165.48K-66,945.12%-219.25K---200.92K---200.92K---226.9K
Total equity -29.86%1.1M-25.77%1.25M-27.43%1.41M-27.43%1.41M-35.34%1.45M-41.70%1.57M-48.37%1.69M424.80%1.94M424.80%1.94M--2.25M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg